Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections

Cancer Medicine

Volumn 4, Issue 8, 2015, Pages 1294-1302

  Depuydt, Christophe E ^a   Jonckheere, Jef ^a   Berth, Mario ^a   Salembier, Geert M ^a   Vereecken, Annie J ^a   Bogers, Johannes J ^a,b  

^a AML   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Cervical intraepithelial neoplasia; Latency; Liquid based cytology; Primary cervical cancer screening; Real time quantitative PCR

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER GRADING; CANCER REGRESSION; CELL POPULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRION; VIRUS LATENCY; VIRUS LOAD; WART VIRUS; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLASSIFICATION; COMPLICATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GENETICS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; VIROLOGY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; VIRAL LOAD; VIRION; VIRUS LATENCY;

EID: 85006226051     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.473     Document Type: Article

References (24)

1. Arbyn, M., X. Castellsague, S. S. de, L. Bruni, M. Saraiya, F. Bray, et al. 2011. Worldwide burden of cervical cancer in 2008. Ann. Oncol. 22:2675-2686.
2. Ylitalo, N., P. Sorensen, A. M. Josefsson, P. K. Magnusson, P. K. Andersen, J. Ponten, et al. 2000. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355:2194-2198.
3. Bosch, F. X., A. Lorincz, N. Munoz, C. J. Meijer, and K. V. Shah . 2002. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:244-265.
4. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, et al. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
5. Nobbenhuis, M. A., J. M. Walboomers, T. J. Helmerhorst, L. Rozendaal, A. J. Remmink, E. K. Risse, et al. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354:20-25.
6. Arbyn, M., S. D. Sanjose, M. Saraiya, M. Sideri, J. Palefsky, C. Lacey, et al. 2012. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int. J. Cancer 131:1969-1982.
7. Depuydt, C. E., A. M. Criel, I. H. Benoy, M. Arbyn, A. J. Vereecken, and J. J. Bogers . 2012. Changes in type-specific human papillomavirus load predict progression to cervical cancer. J. Cell Mol. Med. 16:3096-3104.
8. Arbyn, M., G. Ronco, A. Anttila, C. J. Meijer, M. Poljak, G. Ogilvie, et al. 2012. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30(Suppl 5):F88-F99.
9. Rogoza, R. M., N. Ferko, J. Bentley, C. J. Meijer, J. Berkhof, K. L. Wang, et al. 2008. Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: a multi-regional health economic analysis. Vaccine 26(Suppl 5):F46-F58.
10. Depuydt, C. E., I. H. Benoy, J. F. Beert, A. M. Criel, J. J. Bogers, and M. Arbyn . 2012. Clinical Validation of a type-specific real time quantitative human papillomavirus PCR to the performance of hybrid capture 2 for the purpose of cervical cancer screening. J. Clin. Microbiol. 50:4073-4077.
11. Gravitt, P. E. 2011. The known unknowns of HPV natural history. J. Clin. Invest. 121:4593-4599.
12. Gravitt, P. E. 2012. Evidence and impact of human papillomavirus latency. Open Virol. J. 6:198-203.
13. Moscicki, A. B., Y. Ma, C. Wibbelsman, T. M. Darragh, A. Powers, S. Farhat, et al. 2010. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet. Gynecol. 116:1373-1380.
14. Wang, S. M., D. Colombara, J. F. Shi, F. H. Zhao, J. Li, F. Chen, et al. 2013. Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses. Int. J. Gynecol. Cancer 23:716-723.
15. Bedell, M. A., J. B. Hudson, T. R. Golub, M. E. Turyk, M. Hosken, G. D. Wilbanks, et al. 1991. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65:2254-2260.
16. Pyeon, D., S. M. Pearce, S. M. Lank, P. Ahlquist, and P. F. Lambert . 2009. Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog. 5:e1000318.
17. Bodily, J., and L. A. Laimins . 2011. Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol. 19:33-39.
18. Benoy, I. H., D. Vanden Broeck, M. J. Ruymbeke, S. Sahebali, M. Arbyn, J. J. Bogers, et al. 2011. Prior knowledge of HPV status improves detection of CIN2+ by cytology screening. Am. J. Obstet. Gynecol. 205:569.e1-7.
19. Jordan, J., M. Arbyn, P. Martin-Hirsch, U. Schenck, J. J. Baldauf, S. D. Da, et al. 2008. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 19:342-354.
20. Jordan, J., P. Martin-Hirsch, M. Arbyn, U. Schenck, J. J. Baldauf, S. D. Da, et al. 2009. European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology 20:5-16.
21. Micalessi, I. M., G. A. Boulet, J. J. Bogers, I. H. Benoy, and C. E. Depuydt . 2012. High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR. Clin. Chem. Lab. Med. 50:655-661.
22. Depuydt, C. E., G. A. Boulet, C. A. Horvath, I. H. Benoy, A. J. Vereecken, and J. J. Bogers . 2007. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J. Cell Mol. Med. 11:881-891.
23. Schoonjans, F., A. Zalata, C. E. Depuydt, and F. H. Comhaire . 1995. MedCalc: a new computer program for medical statistics. Comput. Methods Prog. Biomed. 48:257-262.
24. Woo, Y. L., J. Sterling, I. Damay, N. Coleman, R. Crawford, S. H. van der Burg, et al. 2008. Characterising the local immune responses in cervical intraepithelial neoplasia: a cross-sectional and longitudinal analysis. BJOG 115:1616-1621.